From April 1, 2023 to June 30, 2023, the company has repurchased 150,000 shares, representing 0.08% for BRL 3 million. With this, the company has completed the repurchase of 1,713,200 shares, representing 0.96% for BRL 42.89 million under the buyback announced on June 14, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.89 BRL | +5.36% | +0.83% | -33.64% |
Mar. 20 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 | |
Mar. 19 | Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.64% | 378M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- BLAU3 Stock
- News Blau Farmacêutica S.A.
- Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.